Our data suggest that promoting NRP1-dependent signaling could be particularly relevant in age-related diseases characterized by increased oxidative stress or by deregulation of iron metabolism such as atherosclerosis, vascular dementia, and Alzheimer disease. This evidence concerns the gene NRP1 and Alzheimer disease.